PATENT CLAIM ANALYSIS

Application Number: 15865001
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "449000"]

Abstract:
A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunomodulator to an associated sterile container, the associated sterile container having a defined volume of diluted immunomodulator after dilution thereof, providing a viscous encapsulation material, selecting a prescribed amount of concentrated immunomodulator, the prescribed amount defined as that amount of the diluted immunomodulator extract required to provide a number of doses equal to the number of dispensable increments from the container containing the viscous encapsulation material, introducing the selected amount of each of the diluted immunomodulator extract into the viscous encapsulation material, introducing an amount of imiquimod into the viscous encapsulation material, and mixing the introduced amount of each of the diluted immunomodulator extracts and the introduced amount of imiquimod with the viscous encapsulating material.

Claim (Index 8):
The method of  claim 6 , wherein the step of diluting comprises the steps of:\n providing a plurality of sterile containers, each associated with a different dilution level; associated with each container of concentrated immunomodulator extract, extracting a defined amount of concentrated immunomodulator extract from the container of immunomodulator extract and disposing it within a first one of the associated sterile containers containing a dilutant to provide a first dilution level; extracting a defined amount of the diluted immunomodulator extract from the first of the associated sterile containers and disposing it within a second of the associated sterile containers to provide a second dilution level; and progressively extracting a defined amount of diluted immunomodulator extract from a previous one of the associated sterile containers to the next thereof containing a dilutant to provide progressively more diluted levels until the last of the associated sterile containers containing a final dilution level.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 2.4375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15183719', '15222790', '15425863', '11052577', '13946664']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7570780468548999
- 35 USC 102 Novelty (BERT): 0.5586358830741605
- Combined Prediction Score: 0.7372338304768259
- Mean Citation Score: 315.7222720000001
- Max Citation Score: 502.77078
- Similarity Product: 288.92672318984984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test